OptimizeRx Invited to Host Plenary Sessions at Digital Pharma East on September 17-20, 2019
Bringing together more than 1,000 participants, this conference will feature latest case studies and senior-level discussions with pharma companies, health systems, physicians, health-tech companies, startups and non-traditional healthcare companies involved in digital health.
The first plenary session, “Success in Today’s Evolving Pharma Marketing Landscape,” will be hosted by
In this session, Silvestro will be joined by Dr.
The second plenary session, “Innovation and Communication in Today’s Digitally-Charged Pharma Landscape,” will be hosted by
In this session, Paramore will facilitate a panel discussion that includes Dr.
OptimizeRx’s VP of marketing and communications,
About Digital Pharma East
Digital Pharma East is the leading marketing conference globally for life science professionals looking to learn, network and be inspired. For more information, visit www.digitalpharmaseries.com/east.
The cloud-based solution supports patient adherence to medications and better healthcare outcomes with real-time access to financial assistance, prior authorization, education and critical clinical information. OptimizeRx provides more than half of the ambulatory patient market with access to these benefits through leading EHR platforms like Allscripts, Amazing Charts and Quest, and directly via its mobile communications platform.
Important Cautions Regarding Forward Looking Statements
This press release contains forward-looking statements within the definition of Section 27A of the Securities Act of 1933, as amended, and such as in section 21E of the Securities Act of 1934, as amended. These forward-looking statements should not be used to make an investment decision. The words 'estimate,' 'possible' and 'seeking' and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to, the effect of government regulation, competition and other material risks.
Tel (248) 651-6568 x807
Media Relations Contact
Nicole Brooks, Innsena Communications
Tel (860) 800-2344
Investor Relations Contact
Tel (949) 432-7557
Source: OptimizeRx Corporation